SCHEMBL7878733

SCHEMBL7878733

CCCCC[CH]S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.52
MCHR1 Q99705 1/20 0.47
CTSK P43235 1/20 0.45
G6PD P11413 2/20 0.44
ALDH1A1 P00352 8/20 0.44
CYP2C9 P11712 4/20 0.44
CYP2C19 P33261 3/20 0.44
CYP3A4 P08684 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 3/20 0.42
MAPT P10636 2/20 0.42
CYP2D6 P10635 2/20 0.42
NPC1 O15118 1/20 0.42
NFKB1 P19838 1/20 0.42
S100A4 P26447 1/20 0.42
MTOR P42345 1/20 0.42
RAB9A P51151 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8655900 0.98 TLR9 (0.50) TLR9MCHR1CTSKG6PDALDH1A1
SCHEMBL4391248 0.87 TLR9 (0.57) TLR9MCHR1CTSKG6PDALDH1A1
SCHEMBL7330132 0.84 TDP1 (0.47) TLR9ALDH1A1CYP2C9CYP2C19SMN1; SMN2
SCHEMBL5077216 0.82 EPHX2 (0.47) TLR9ALDH1A1TDP1TSHR
SCHEMBL4398844 0.79 TLR9 (0.61) TLR9CTSKG6PDALDH1A1CYP2C9
SCHEMBL7768688 0.77 TLR9 (0.46) TLR9MCHR1CTSKG6PDALDH1A1
Hexane SCHEMBL7122950 0.73 MCHR1 (0.53) MCHR1G6PDALDH1A1CYP2C9CYP2C19
Hexane SCHEMBL11658743 0.73 MCHR1 (0.53) TLR9MCHR1G6PDALDH1A1CYP2C9
SCHEMBL28433005 0.72 TLR9 (0.44) TLR9MCHR1CTSKALDH1A1CYP2C9
Decane SCHEMBL17004268 0.72 MCHR1 (0.56) MCHR1G6PDALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0573218-B1 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use SANKYO CO (JP) 2001-03-07 EP disclosed